|
1
|
Murray CJ and Lopez AD: Alternative
projection of mortality and disability by cause 1990–2020: Global
Burden of Disease Study. Lancet. 349:1498–1504. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murry CE, Jennings RB and Reimer KA:
Preconditioning with ischemia: a delay of lethal cell injury in
ischemic myocardium. Circulation. 74:1124–1136. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Philipp S, Yang XM, Cui L, et al:
Postconditioning protects rabbit hearts through a protein kinase
C-adenosine A2b receptor casade. Cardiovasc Res. 70:308–314. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tissier R, Cohen MV and Downey JM:
Protecting the acutely ischemic myocardium beyond reperfusion
therapies: are we any closer to realizing the dream of infarct size
elimination? Arch Mal Coeur Vaiss. 100:794–802. 2007.PubMed/NCBI
|
|
6
|
Gross ER, Hsu AK and Gross GJ:
Opioid-induced cardioprotection occurs via glycogen synthase kinase
beta inhibition during reperfusion in intact rat hearts. Circ Res.
94:960–966. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tissier R, Waintraub X, Couvreur N, et al:
Pharmacological postconditioning with the phytoestrogen genistein.
J Mol Cell Cardiol. 42:79–87. 2007. View Article : Google Scholar
|
|
8
|
Efthymiou CA, Mocanu MM and Yellon DM:
Atorvastatin and myocardial reperfusion injury: new pleiotropic
effect implicating multiple prosurvival signaling. J Cardiovasc
Pharmacol. 45:247–252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao YQ, Zhao GP and Jiang RW:
Determination of ferulic acid serum concentration in Danggui Sini
Decotion by HPLC and its pharmacokinetics in rats. Zhong Cheng Yao.
33:419–422. 2011.(In Chinese).
|
|
10
|
Gao YQ, Wu J, Jiang RW and Zhao GP:
Determination of cinnamic acid and glycyrrhizic acid in rat serum
and its pharmacokinetics after oral administration of Dangguisini
decoction. Zhong Yao Cai. 34:408–411. 2011.(In Chinese). PubMed/NCBI
|
|
11
|
Zhao X, Gu Y, Song XX, et al: Simultaneous
determination of four main components in Dangguisini decoction.
Shenyang Yao Ke Da Xue Xue Bao. 13:200–203. 2008.(In Chinese).
|
|
12
|
Nagai T, Egashira T, Yamanaka Y and Kohno
M: The protective effect of glycyrrhizin against injury of the
liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol.
20:432–436. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abdugafurova MA, Li VS, et al:
Antioxidative properties of glycyrrhyzic acid salts and their
effect on the liver monooxygenase system. Vopr Med Khim. 36:29–31.
1990.(In Russian). PubMed/NCBI
|
|
14
|
Yokozawa T, Liu ZW and Chen CP: Protective
effects of Glycyrrhizae radix extract and its compounds in a renal
hypoxia (ischemia)-reoxygenation (reperfusion) model.
Phytomedicine. 6:439–445. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kilgore KS, Tanhehco EJ, Park JL, et al:
Reduction of myocardial infarct size in vivo by carbohydrate-based
glycomimetics. J Pharmacol Exp Ther. 284:427–435. 1998.PubMed/NCBI
|
|
16
|
Nagai T, Egashira T, Kudo Y, Yamanaka Y
and Shimada T: Attenuation of dysfunction in the
ischemia-reperfused liver by glycyrrhizin. Jpn J Pharmacol.
58:209–218. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cartron E, Carbonneau MA, et al: Specific
antioxidant activity of caffeoyl derivatives and other natural
phenolic compounds: LDL protection against oxidation and decrease
in the proinflammatory lysophosphatidylcholine production. J Nat
Prod. 64:480–486. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Banskota AH, Nagaoka T, Sumioka LY, et al:
Antiproliferative activity of the Netherlands propolis and its
active principles in cancer cell lines. J Ethnopharmacol. 80:67–73.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neto CC: Cranberry and blueberry: evidence
for protective effects against cancer and vascular diseases. Mol
Nutr Food Res. 51:652–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang X, Qin F, Zhang HM, et al:
Cardioprotection by Guanxin II in rats with acute myocardial
infarction is related to its three compounds. J Ethnopharmacol.
121:268–273. 2009. View Article : Google Scholar
|
|
21
|
Yogeeta SK, Raghavendran HR, Gnanapragasam
A, et al: Ferulic acid with ascorbic acid synergistically
extenuates the mitochondrial dysfunction during beta-adrenergic
catecholamine induced cardiotoxicity in rats. Chem Biol Interact.
163:160–169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wolfrum S, Richardt G, Dominiak P, et al:
Apstatin, a selective inhibitor of aminopeptidase P, reduces
myocardial infarct size by a kinin-dependent pathway. Br J
Pharmacol. 134:370–374. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murota S, Fujita H, Wakabayashi Y and
Morita I: Cell adhesion molecule mediates endothelial cell injury
caused by activated neutrophils. Keio J Med. 45:207–211. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
López-Cacho JM, González-R PL, et al:
Robust optimization of alginate-Carbopol 940 bead formulations.
ScientificWorldJournal. 2012:6056102012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou J, Sun JB, Zheng P, et al: Orthogonal
array design for optimization of hollow-fiber-based liquid-phase
microextraction combined with high-performance liquid
chromatography for study of the pharmacokinetics of magnoflorine in
rat plasma. Anal Bioanal Chem. 403:1951–1960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Zhang Y, Li Y, et al: Growth
promotion of Yunnan pine early seedlings in response to foliar
application of IAA and IBA. Int J Mol Sci. 13:6507–6520. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cerqueira NF, Hussni CA and Yoshida WB:
Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta
Cir Bras. 20:336–343. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burley DS, Ferdinandy P and Baxter GF:
Cyclic GMP and protein kinase-G in myocardial
ischaemia-reperfusion: opportunities and obstacles for survival
signaling. Br J Pharmacol. 152:855–869. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen HP, Liao ZP, Huang QR and He M:
Sodium ferulate attenuates anoxia/reoxygenation-induced calcium
overload in neonatal rat cardiomyocytes by NO/cGMP/PKG pathway. Eur
J Pharmacol. 603:86–92. 2009. View Article : Google Scholar
|
|
30
|
Howes MJ, Perry NS and Houghton PJ: Plants
with traditional uses and activities, relevant to the management of
Alzheimer’s disease and other cognitive disorders. Phytother Res.
17:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Point D, Coudert P, Leal F, et al:
Antioxidant activity of some ascorbic and cinnamic acids
derivatives. Farmaco. 53:85–88. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jeong HG, You HJ, Park SJ, et al:
Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon
tetrachloride-induced liver injury: inhibition of cytochrome P450
2E1 expression. Pharmacol Res. 46:221–227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jaeschke H: Mechanisms of liver injury. II
Mechanisms of neutrophil-induced liver cell injury during hepatic
ischemia-reperfusion and other acute inflammatory conditions. Am J
Physiol Gastrointest Liver Physiol. 290:G1083–G1088. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Spanos CP, Papaconstantinou P, Spanos P,
et al: The effect of L-arginine and aprotinin on intestinal
ischemia-reperfusion injury. J Gastrointest Surg. 11:247–255. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sima N, Lü W and Xie X: Early proteins E6
and E7 of human papillomavirus may attenuate ischemia-reperfusion
injury. Med Hypotheses. 76:607–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Olanders K, Sun Z, Börjesson A, et al: The
effect of intestinal ischemia and reperfusion injury on ICAM-1
expression, endothelial barrier function, neutrophil tissue influx,
and protease inhibitor levels in rats. Shock. 18:86–92. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Venardos KM, Perkins A, Headrick J and
Kaye DM: Myocardial ischemia-reperfusion injury, antioxidant enzyme
systems and selenium: a review. Curr Med Chem. 14:1539–1549. 2007.
View Article : Google Scholar
|
|
38
|
Di Paola R, Menegazzi M, Mazzon E, et al:
Protective effects of glycyrrhizin in a gut hypoxia
(ischemia)-reoxygenation (reperfusion) model. Intensive Care Med.
35:687–697. 2009. View Article : Google Scholar
|
|
39
|
Cepinskas G, Rui T and Kvietys PR:
Interaction between reactive oxygen metabolites and nitric oxide in
oxidant tolerance. Free Radic Biol Med. 33:433–440. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li C, Browder W and Kao RL: Early
activation of transcription factor NF-kappaB during ischemia in
perfused rat heart. Am J Physiol. 276:H543–H552. 1999.PubMed/NCBI
|
|
41
|
Inoue I, Goto S, Matsunaga T, et al: The
ligands/activators for peroxisome proliferator-activated receptor
alpha (PPARalpha) and PPARgamma increase Cu2+,
Zn2+-superoxide dismutase and decrease p22phox message
expressions in primary endothelial cells. Metabolism. 50:3–11.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yoo HY, Chang MS and Rho HM: Induction of
the rat Cu/Zn superoxide dismutase gene through the peroxisome
proliferator-responsive element by arachidonic acid. Gene.
234:87–91. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ding GL, Cheng L, et al: PPARdelta
modulates lipopolysaccharide-induced TNFalpha inflammation
signaling in cultured cardiomyocytes. J Mol Cell Cardiol.
40:821–828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Inoue I, Noji S, Awata T, et al:
Bezafibrate has an antioxidant effect: peroxisome
proliferator-activated receptor alpha is associated with
Cu2+, Zn2+-superoxide dismutase in the liver.
Life Sci. 63:135–144. 1998. View Article : Google Scholar
|
|
45
|
Marx N, Duez H, Fruchart JC and Staels B:
Peroxisome proliferator-activated receptors and atherogenesis:
regulators of gene expression in vascular cells. Circ Res.
94:1168–1178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Marx N, Sukhova GK, et al: PPARalpha
activators inhibit cytokine-induced vascular cell adhesion
molecule-1 expression in human endothelial cells. Circulation.
99:3125–3131. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bulhak AA, Jung C, Ostenson CG, et al:
PPARalpha activation protects the type 2 diabetic myocardium
against ischemia-reperfusion injury: involvement of the
PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol.
296:H719–H727. 2009. View Article : Google Scholar : PubMed/NCBI
|
